Key facts
- This page summarizes Quan Anh Vu's Form 3 filing for Ocugen, Inc. (OCGN).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Mar 2023, 18:26.
Quan Anh Vu - 06 Mar 2023 Form 3 Insider Report for Ocugen, Inc. (OCGN)
- Reporting relationship
- CFO/CBO
- Issuer ticker
- OCGN
- Reported as of
- 06 Mar 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Mar 2023, 18:26:20 UTC
- Prior SEC filing
- 16 Dec 2021
- Next SEC filing
- 05 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Quan Anh Vu
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Quan Anh Vu filed Form 3 for Ocugen, Inc. (OCGN) on 10 Mar 2023.
Change
- Previous filing in this sequence was filed on 16 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OCGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 165,934
- Date
- 06 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OCGN
holding
Derivative
Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 196,850
- Exercise price
- $1.04
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 163,934 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Ocugen, Inc. (the "Company"). The RSUs vest annually in equal installments over three years commencing on February 16, 2024, in each case subject to continued service with the Company on the applicable vesting dates. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
Footnote F2
The option vests annually in equal installments over three years commencing on February 16, 2024, subject to continued service with the Company on the applicable vesting dates.
SEC remarks
Exhibit List: Exhibit 24.1 - Power of Attorney.